Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$825K Sell
15,933
-95
-0.6% -$4.93K 0.19% 100
2021
Q4
$946K Buy
16,028
+27
+0.2% +$1.34K 0.21% 97
2021
Q3
$803K Buy
+16,001
New +$709K 0.17% 110
2021
Q2
Sell
-14,921
Closed -$541K 151
2021
Q1
$541K Buy
14,921
+42
+0.3% +$1.49K 0.14% 127
2020
Q4
$548K Buy
14,879
+405
+3% +$14.9K 0.15% 119
2020
Q3
$504K Buy
14,474
+364
+3% +$12.8K 0.16% 111
2020
Q2
$438K Sell
14,110
-1,287
-8% -$43.7K 0.15% 118
2020
Q1
$477K Buy
15,397
+28
+0.2% +$954 0.21% 97
2019
Q4
$571K Buy
+15,369
New +$547K 0.2% 105
2019
Q2
Sell
-4,437
Closed -$179K 491
2019
Q1
$179K Hold
4,437
0.07% 169
2018
Q4
$184K Sell
4,437
-295
-6% -$12.2K 0.08% 154
2018
Q3
$198K Sell
4,732
-350
-7% -$13.5K 0.08% 153
2018
Q2
$175K Sell
5,082
-20,175
-80% -$689K 0.07% 160
2018
Q1
$850K Sell
25,257
-10,372
-29% -$357K 0.34% 61
2017
Q4
$1.22M Sell
35,629
-444
-1% -$15.1K 0.44% 54
2017
Q3
$1.22M Sell
36,073
-32
-0.1% -$1.03K 0.6% 37
2017
Q2
$1.15M Buy
+36,105
New +$1.14M 0.54% 36

Other funds holding PFE

Ferris Capital's PFE Position: Q1 2022 in Review

Ferris Capital reduced its Pfizer (PFE) stake by 0.59% in Q1 2022, selling an estimated $4.93K and leaving 15,933 shares worth $825K. The position accounts for 0.19% of the portfolio, ranked #100.

Ferris Capital first reported a position in PFE in Q2 2017 and has held it in 17 quarters since. The position peaked at $1.22M in Q4 2017. 3,196 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Ferris Capital held 15,933 shares of Pfizer worth $825K as of Q1 2022.
  • Ferris Capital sold 95 Pfizer shares in Q1 2022, an estimated $4.93K.
  • Pfizer made up 0.19% of Ferris Capital's portfolio in Q1 2022, its #100 holding.
  • Ferris Capital first reported a position in Pfizer in Q2 2017 and has held it in 17 quarters since.
  • Ferris Capital's Pfizer position peaked at $1.22M in Q4 2017.
  • 3,196 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Ferris Capital's 13F filing for Q1 2022, filed 13 May 2022.